HOME >> MEDICINE >> NEWS
Studies compare hysterectomy vs. other medical treatments for abnormal uterine bleeding

s. 2), and satisfaction with health (31 vs. 14). By the end of the two-year follow-up, 17 (53 percent) of the women in the medicine group had requested and received hysterectomy, and these women reported improvements in quality-of-life outcomes during the two years that were similar to those reported by women randomized to the hysterectomy group. Women who continued in the medical treatment also reported some improvements, with the result that most differences between randomized groups at the end of the study were no longer statistically significant in the intention-to-treat analysis."

"We have shown that hysterectomy results in substantial improvement in health-related quality of life within six months for women who have not responded to medroxyprogesterone. Persisting efforts at medical treatment can also produce benefits for many of these women throughout the ensuing two years although others who prolong medical treatment at this stage will decide within a year to have a hysterectomy," the authors conclude.

(JAMA 2004; 291:1447-1455. Available post-embargo at JAMA.com)

Editor's Note: This research was funded by a grant from the Agency for Healthcare Research and Quality.

FINNISH STUDY COMPARES INTRAUTERINE HORMONE-DELIVERY SYSTEM VS. HYSTERECTOMY

In a second study in the March 24/31 issue of JAMA, researchers from Finland compare outcomes, quality-of-life issues, and costs of the levonorgestrel-releasing intrauterine system (LNG-IUS) versus hysterectomy in the treatment of menorrhagia (abnormally heavy menstrual bleeding).

"The LNG-IUS is an intrauterine system that releases 20 [micrograms] of levonorgesterel every 24 hours over 5 years. The LNG-IUS was developed during the 1980s and licensed first for contraception in Finland in 1990," the authors provide as background information. They add that in many countries, the LNG-IUS is licensed both for contraception and trea
'"/>

Contact: Eve Harris
415-885-7277
JAMA and Archives Journals
23-Mar-2004


Page: 1 2 3 4

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies demonstrate positive data in treatment of hepatitis C
8. Studies examine risk factors and potential consequences associated with prehypertension
9. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
10. Studies identify risk factors for colon cancer
11. Studies indicate healthy eating may affect cancer development, improve digestive system

Post Your Comments:
(Date:2/27/2015)... 27, 2015 The report analyzes the ... the global celiac disease market. It also assesses key ... development activities, and investments. , Celiac disease is an ... the small intestine. Celiac disease often has a genetic ... people is affected by celiac disease across the globe. ...
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 UAS ... Adult Cubes, at Natural Products Expo West, March 6 ... are very excited to release the hands down best ... cream taste with an extra zing of Vitamin C. ... Cubes, winner of the NutrAward 2014, Delicious Living’s Supplement ...
(Date:2/27/2015)... 27, 2015 The Willliams Companies Inc ... Lincoln County, Wyoming. The plant processes natural gas ... interstate natural gas pipeline transport. It also produces natural ... plant initially began operations in 1958, and in recent ... gas production in Wyoming. The plant currently has ...
(Date:2/27/2015)... The Connecticut Community for Addiction Recovery ... Alcohol and Drug Recovery Centers (ADRC), for its shared ... were honored with the 2014 Commissioner’s Recognition Award by ... Last year, ROES achieved the highest rate ... are recovering from alcoholism and other drug addiction. ...
(Date:2/27/2015)... 2015 First Choice Emergency Room ... today. The new facility is located 25551 E. Smoky Hill ... are pleased to be a part of the Aurora community ... care here,” said Dr. Dombro, Facility Medical Director of First ... To celebrate the opening, First Choice Emergency Room made a ...
Breaking Medicine News(10 mins):Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2Health News:First Choice Emergency Room Opens New Facility in Aurora, Colorado 2
(Date:2/26/2015)... , Feb. 26, 2015  Unetixs ... noninvasive peripheral vascular physiologic testing solutions, today ... SSI, FR0010526814), the highly innovative medical imaging ... Doppler to bring SuperSonic Imagine,s technology to ... Unetixs SSI Aixplorer Ultrasound System combines ...
(Date:2/26/2015)... WORTH, Texas , February 26, 2015 ... Boston Scientific, Inc. (U.S) are the leaders in the ... , and Turkish neuromodulation market and is expected to lead ... in 1949, Medtronic, Inc. is the top player in the ... of implants for specific applications. Interstim and Entera Neurostimulator are ...
(Date:2/26/2015)... 2015 ANSYS (NASDAQ: ANSS ) ... diesel engines and global power leader, Cummins Inc., has ... to the ANSYS ® portfolio. This enterprise license ... of the industry,s most challenging multiphysics problems – providing ... on the market. The multi-year agreement provides ...
Breaking Medicine Technology:Unetixs Vascular Announces Partnership with SuperSonic Imagine 2Unetixs Vascular Announces Partnership with SuperSonic Imagine 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4Cummins Standardizes On ANSYS Engineering Simulation Software 2Cummins Standardizes On ANSYS Engineering Simulation Software 3
Cached News: